The Long Non-Coding RNA AC006329.1 Facilitates Hepatocellular Carcinoma Progression and Metastasis by Regulating miR-127-5p/SHC3/ERK Axis
Xiang Xu Kong,Xiao Yang,Wang Jie Jiang,De Ming Zhu,Lian Bao Kong
DOI: https://doi.org/10.2147/JHC.S415309
2023-07-18
Journal of Hepatocellular Carcinoma
Abstract:Xiang Xu Kong, 1, &ast Xiao Yang, 1, &ast Wang Jie Jiang, 1, &ast De Ming Zhu, 1, 2 Lian Bao Kong 1, 2 1 Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210000, People's Republic of China; 2 Key Laboratory of Liver Transplantation, Chinese Academy of Medical Sciences, NHC Key Laboratory of Living Donor Liver Transplantation, Nanjing Medical University, Nanjing, 210000, People's Republic of China &astThese authors contributed equally to this work Correspondence: Lian Bao Kong, Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210000, People's Republic of China, Tel +86-138-0158-3199, Email Purpose: Hepatocellular carcinoma(HCC) is the most common type of liver cancer and the sixth largest common cancer worldwide. Although surgical resection, hepatic arterial chemoembolization, targeted drugs and immunotherapy are currently available, the mortality of advanced patients remains high. Therefore, new therapeutic targets are urgently needed. In recent years, many studies have found that The long non-coding RNA(lncRNA) has multiple functions in human tumors, including participating in epigenetic, transcriptional, post-transcriptional and translational regulation, and is closely related to the progression of HCC. The purpose of this study was to investigate the role of AC006329.1 in HCC progression and provide theoretical guidance for finding new targets. Patients and Methods: AC006329.1 was screened out by transcriptome sequencing and quantitative real-time polymerase chain reaction (qRT-PCR). Then a series of functional tests in vivo and in vitro were conducted to investigate the effects of AC006329.1 on HCC progression and metastasis. Epithelial-mesenchymal transformation (EMT) of HCC was detected by Western blot and immunofluorescence staining. The targeted miRNA and downstream gene of AC006329.1 were predicted by databases and the pathway regulation axis eventually validated by dual luciferase reporter assays, qRT-PCR and WB. Results: AC006329.1 was found high expressed in HCC tissues and cell lines by qRT-PCR. The prognosis of HCC patients with high expressed AC006329.1 was poor. In vitro and in vivo, overexpression of AC006329.1 can promote the progression, metastasis and EMT of HCC by acting as a sponge of miR-127-5p to increase the expression of SHC3. In addition, up-regulation of miR-127-5p or knockdown of SHC3 can both reverse the promoting effects of AC006329.1 on progression, metastasis and EMT of HCC. Finally, WB and qRT-PCR analysis was discovered that AC006329.1 can facilitate HCC progression, EMT and metastasis by competitively inhibiting miR-127-5p to activate SHC3/ERK signaling pathway. Conclusion: These above experimental results confirmed that AC006329.1 can facilitate HCC progression, EMT and metastasis by acting as a competing endogenous RNA (ceRNA) to inhibit miR-127-5p and activate SHC3/ERK signaling pathway. Keywords: AC006329.1, miR-127-5p, SHC3, EMT, HCC Hepatocellular carcinoma (HCC) is one of the most common malignancies and the third most common cause of cancer-related death in the world, especially in Africa and East Asia. 1 Due to the lack of early specific symptoms, HCC patients were usually diagnosed late and have a poor prognosis. Advanced HCC Patients can only be treated conservatively, such as chemotherapy, interventional therapy, radiotherapy, and targeted immunotherapy to prolong survival. Although there are many therapeutic methods for HCC, it seems that the prognosis and curative effects are hardly satisfactory. 2 To significantly improve the prognosis of HCC, further studies are needed for us to better understand the molecular mechanisms of HCC and identify other novel molecular targets for effective intervention in HCC. Long non-coding RNAs (LncRNAs) are more than 200nt in length and were previously considered to be non-protein-coding; however, they may have shorter open reading frames (ORFs). Many studies have shown that lncRNAs have multiple functions in humans and animals, including epigenetic regulation, transcriptional, post-transcriptional and translational regulation, and post-translational modification. 3 For example, the prognosis of HCC patients with high expressed LncRNA-MCM3AP-AS1 is poor. Knockout of MCM3AP-AS1 inhibits the proliferation cell cycle progression of HCC cells, and promote the apoptosis of HCC cells. In terms of mechanism, MCM3AP-AS1 binds to miR-194-5p as a carcinogenic lncRNA, thus promoting the expression of FOXA1. 4 MicroRNAs (miRNAs or miRs) is a non-coding single-stranded multifunctional -Abstract Truncated-
oncology